Novo Nordisk lowering prices for weight loss, diabetes drugs for cash customers
Novo Nordisk announced Monday it is lowering the costs of weight loss and diabetes drugs, just weeks after striking a deal with the Trump administration to lower prices for customers. Wegovi 0.25 mg and 0.5 mg injection and Ozempic will cost $199 per month for new self-pay patients through March 31, 2026, Novo Nordisk… Source…
